Thursday, April 19, 2012 10:49:17 AM
another major drug company could come in with
a more substantial offer. remember, even though
they would not have total rights and profits, they would
have 50% share of -gsk- profits.
that would " in my opinion," twist -gsk- arm to increase
they're bid substantially, just to deter potential buyers.
i think this share price will go to $20. to $25.
it will be interesting to watch.
" I COULD BE WRONG!!"
just remember: this stock was trading at $30.00
exactly one year ago. { 52 week high - 4/28/11
From: Kevin Hyatt <Kevin.Hyatt@comporium.com>
To: Robert Chaney <robertchaneygto@yahoo.com>
Sent: Thursday, April 19, 2012 10:07 AM
Subject: GlaxoSmithKline pounces on Human Genome with $2.6 billion bid
I thought you might be interested in this:
http://reut.rs/IAuCxJ
I found this using the Thomson Reuters News Pro for iPhone app.
To install News Pro on your iPhone or iPad, visit:
http://reuters.com/mobile
Have a great day,
Kevin
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM